Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
iaslc
May 19, 2024, 06:05 |
Insight
Herbert Loong: Our latest recommendations for NTRK fusion testing and management in lung cancer
Herbert Loong shared on X: "We have recently published our latest recommendations for NTRK fusion…
May 18, 2024, 10:01 |
Blog
Herbert Loong: We are thrilled to have our new dean Philip Chiu visit our small department of clinical oncology
Herbert Loong shared on X/Twitter: ''We are thrilled to have our new Dean of CUHK Medicine,…
May 18, 2024, 09:06 |
Blog
Jarushka Naidoo: Perioperative Nivolumab in Stage IIA-IIIB NSCLC
Jarushka Naidoo shared on X/Twitter: ''Ph III CM77T trial at NEJM: Perioperative Nivolumab in Stage…
May 18, 2024, 08:33 |
Blog
Rami Manochakian: Results of Checkmate 77T trial of
Rami Manochakian shared a post on X/Twitter: ''Hot Off The Press. Just published at NEJM.…
May 16, 2024, 15:01 |
Blog
Stephen Liu: Upcoming Virtual Tumor Board episode with Drs. Apar Kishor Ganti and Sze Wai Chan
Stephen Liu shared on X: “Watch for this upcoming Virtual Tumor Board episode of the IASLC…
May 14, 2024, 15:44 |
Blog
Stephen Liu: The latest updates on targeting RET in lung cancer
Stephen Liu shared on X/Twitter: "For the latest updates on targeting RET in lung cancer, listen…
May 14, 2024, 15:11 |
Blog
Stephen Liu: A free comprehensive CME symposium on targeted therapy in NSCLC
Stephen Liu shared on X: "Saturday, June 1, 7 pm CDT at ASCO24 - join…
May 13, 2024, 14:29 |
Insight
Jarushka Naidoo: A step forward in implementing anti-PD(L)1 across growing not otherwise specified of indications?
Jarushka Naidoo shared on X: "Ph III IMscin001 trial of Subcutaneous (sc) vs IV Atezolizumab…
May 12, 2024, 13:31 |
Blog
Stephen Liu: Update from phase 3 IMscin001 trial JTO and JTO CRR
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: “Update from…
May 12, 2024, 12:13 |
Insight
Herbert Loong: 6 versus 3 years of adjuvant imatinib in high risk GISTs by Jean-Yves Blay et al.
Herbert Loong shared on LinkedIn: “Congrats Jean-Yves Blay and colleagues of French Sarcoma Group for completing…
22
23
24
25
26
All:
319
Posts:
231 - 240
Matti Aapro is running for the UICC Board of Directors
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
Facebook
RSS Feed
Twitter
Linkedin
Youtube